Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2005
11/03/2005US20050244510 Compositions for improving mental performance
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/03/2005US20050244474 Steroid-containing sustained release intraocular implants and related methods
11/03/2005US20050244468 Sustained release intraocular implants and related methods
11/03/2005US20050244417 Using mixture comprising human estrogen specific immunoglobulin and tumor necrosis factor related apoptosis inducing ligand (APO-2L) for use as tool to enhance apoptosis in cancer cells
11/03/2005US20050244414 Method to ameliorate osteolysis and metastasis
11/03/2005US20050244413 Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents
11/03/2005US20050244409 Erythropoietin receptor antibodies
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244393 Sealant or tissue generating product
11/03/2005US20050244392 Probiotic strains, a process for the selection of them, compositions thereof, and their use
11/03/2005US20050244391 Compositions and methods for inhibiting pathogenic growth
11/03/2005US20050244390 Compositions and methods for inhibiting pathogenic growth
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244385 Intradermal cellular delivery using narrow gauge micro-cannula
11/03/2005US20050244383 Method and device for sanitation using bacteriophages
11/03/2005US20050244372 Interleukin-3 (IL-3) multiple mutation polypeptides
11/03/2005US20050244340 Dry powder compositions
11/03/2005US20050241658 Composition to reduce or quit smoking addiction
11/03/2005CA2567249A1 Lithium combinations, and uses related thereto
11/03/2005CA2564353A1 Galantamine salts, method of producing it and nasal composition thereof
11/03/2005CA2564137A1 Treatment of fungal infections
11/03/2005CA2563754A1 Recombinant polypeptides of the members of the tnf ligand family and use thereof
11/03/2005CA2563744A1 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye
11/03/2005CA2563743A1 New pharmaceutical compositions for the treatment of sexual disorders ii
11/03/2005CA2563377A1 Methods of using and compositions comprising pde4 modulators for the treatment and management of pulmonary hypertension
11/03/2005CA2563356A1 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists
11/03/2005CA2561553A1 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
11/03/2005CA2561146A1 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1h-pyrrolo[2-,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine for use in treating hiv infection
11/02/2005EP1591135A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
11/02/2005EP1590328A2 (2-carboxamido) (3-amino) thiophene compounds
11/02/2005EP1590046A2 Composition for the treatment of hiv or aids
11/02/2005EP1590033A2 Drug delivery device having coated microprojections incorporating vasoconstrictors
11/02/2005EP1589998A2 Uses of mammalian cytokine; related reagents
11/02/2005EP1589965A1 Methods and dosage forms for reducing heart attacks in a hypertensive individual with a diuretic or a diuretic and an ace inhibitor combination
11/02/2005EP1589959A2 Methods of treating lower urinary tract disorders using sodium channel modulators
11/02/2005EP1589945A1 Topical pharmaceutical and/or cosmetic dispense systems
11/02/2005EP1589941A1 Composition for preventive treatment of cold sores
11/02/2005EP1589834A1 Enteral composition for the prevention and/or treatment of sepsis
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1307227B1 Pharmaceutical compositions
11/02/2005EP1268524B1 Binding peptides for carcinoembryonic antigen (cea)
11/02/2005EP1200123B1 Diagnosis and treatment of neuroectodermal tumors
11/02/2005EP1177190B1 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/02/2005EP1102767B1 Substituted pyrazole derivatives
11/02/2005EP1083905B1 Medical use of a selective estrogen receptor modulator in combination with a sex steroide precursor
11/02/2005EP1067944B1 Combined preparation comprising monocyte derived cells and chemotherapy drugs for the treatment of neoplasic diseases or of infectious diseases
11/02/2005EP1061873B1 Use of glyceraldehyde as corneal hardening agents
11/02/2005EP1009414B1 Novel pharmaceutical composition comprising clindamycin and clotrimazol for the treatment of vaginal infections
11/02/2005CN1692161A Treatment for asthma or allergies
11/02/2005CN1692116A Adenosine A2A receptor antagonists
11/02/2005CN1691964A Epitope sequences
11/02/2005CN1691946A Application of tacrolimus (FK056) derivant united with beta2-excitomotor for treating asthma
11/02/2005CN1691943A Cancer treatment with go6976 and its related compounds
11/02/2005CN1691941A Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment
11/02/2005CN1691936A Combined immediate release and extended release analgesic composition
11/02/2005CN1689648A Purpose of a medicine composition in preparing medicament for enhancing effect of radiation therapy and chemotherapy
11/02/2005CN1689647A Antifungal medicine composition
11/02/2005CN1689576A Magnetic slow release 5-aminosalicylic acid with intercalate structure and its preparation method
11/02/2005CN1225648C Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
11/02/2005CN1225463C Arylated furane and thenoyl amine with potassium channel blocking effect
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960558 Method of screening for anti-obesity agents using ciliary neutrophic factor receptor
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960359 Comprising cedrol, cedrenol, farnesol, patchouli alcohol or vetiverol; antiallergic agents and atopic dermatitis preventives
11/01/2005US6960357 Controlled release; drugs mixed with inert ingredients compressed into tablets
11/01/2005US6960352 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005US6960300 Process for preparing water soluble diterpenes and their applications
11/01/2005CA2442066C Pd-1, a receptor for b7-4, and uses therefor
11/01/2005CA2115792C Method for the treatment of pain
10/2005
10/27/2005WO2005101838A2 Piperazinylpiperidine derivatives as chemokine receptor antagonists
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100567A1 Gene encoding guanine nucleotide exchange factor and its gene product
10/27/2005WO2005100370A1 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
10/27/2005WO2005099764A1 Antifungal composition for external use
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005099758A2 Injectable bioartificial tissue matrix
10/27/2005WO2005099747A1 Selective killing of cancer cells by induction of acetyltransferase via tnf-alpha and il-6
10/27/2005WO2005099736A1 Antitumor remedy
10/27/2005WO2005099713A2 Novel antiviral pharmaceutical composition
10/27/2005WO2005099705A2 Preparation of imidazole derivatives and methods of use
10/27/2005WO2005099700A1 Methods for the treatment of hypertension
10/27/2005WO2005099696A1 Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
10/27/2005WO2005099672A1 A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
10/27/2005WO2005072740A3 Anorectic compounds
10/27/2005WO2005065685A8 Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
10/27/2005WO2005048912A3 Methods and compositions for the treatment of helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds
10/27/2005WO2005046567B1 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
10/27/2005WO2005034728A3 Colon cleansing composition and method
10/27/2005WO2005030144A3 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
10/27/2005WO2004100867A3 Method and kit for regulation of microvascular tone
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239890 Methods for decreasing detrusor muscle overactivity
1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 1151